Skip to main content

Table 1 Patient characteristics

From: Response to gefitinib and erlotinib in Non-small cell lung cancer: a retrospective study

 

Gefitinib

Erlotinib

 

No

%

No

%

TOTAL

115

 

45

 

Gender

    

   Female

55

48

30

67

   Male

60

52

15

33

Age

    

   Avg. age

66.53

 

66.76

 

   Range

45-86

 

35-82

 

Smoking history

    

   Smokers

109

95

39

87

   Non-smokers

5

1

4

9

   Unknown

1

1

2

4

   Avg. pack-years

43.6

 

42.2

 

Histology

    

   Adenocarcinoma

54

47

15

33

   Squamous

27

23

9

20

   Bronchioalveolar

8

6

2

4

   Large cell

6

5

0

0

   Mixed

2

2

0

0

   NSC not further specified

17

15

20

44

Avg. ECOG

1.37

 

1.37

 

Avg. previous lines of chemo

1.26

 

1.13

 
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us